Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been ...

Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been ...

An ingredient in the hair dye a French woman used caused her to develop a vision-robbing retinopathy, researchers report.

In a new survey, 56% of respondents said they plan to get a flu shot this fall, while just 43% said they'll get an updated ...

Here are four big drug/biotech stocks, LLY, RHHBY, NVS and PFE, which you should buy today for lucrative long-term returns.

Demand for Eli Lilly’s Zepbound and Mounjaro has outstripped supply over the last year, forcing the company to invest heavily ...

Eli Lilly has again upped the ante in scaling up its manufacturing footprint, this time revealing an investment totaling $1.8 billion to expand production capacity at two plants in Ireland. | Eli ...

Pharmaceutical giant Eli Lilly (LLY) says it will spend $1.8 billion U.S. to expand its manufacturing capacity as it tries to ...

Eli Lilly (LLY) has long been a reliable name in the healthcare sector, providing stability for investors during periods of ...

The next generation of Alzheimer’s therapeutics is moving away from amyloid plaques and tau tangles, offering multiple ...

Chicago, IL – September 12, 2024 – Zacks Equity Research shares Eli Lilly LLY as the Bull of the Day and Hertz Global HTZ as the Bear of the Day. In addition, Zacks Equity Research provides analysis ...

A Hartsville hospital patient is among the first in the United States to receive a new treatment that helps slow the ...